EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands

Annukka Kallinen iD, Karine Mardon iD, Samuel Lane, Andrew P Montgomery iD, Rajiv Bhalla, Damion H R Stimson, Muneer Ahamed iD, Gary J Cowin, David Hibbs iD, Eryn L Werry, Roger Fulton iD, Mark Connor iD und 1 weitere

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Annukka Kallinen und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Positron-Emission Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroinflammatory DiseasesPositron-Emission TomographyRatsMiceAnimalsIndolesBrainRadiopharmaceuticalsFluorine RadioisotopesReceptor, Cannabinoid, CB2Aza Compounds

Stichwörter der Autor:innen

CB2 radioligandCu-mediated fluorinationLPSaryl boronatefluorine-18neuroinflammation

Substanzen

IndolesRadiopharmaceuticalsFluorine RadioisotopesReceptor, Cannabinoid, CB25-azaindoleAza Compounds

Autor:innen und Institutionen

  • School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
  • ARC Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Sydney Pharmacy School, The University of Sydney, Sydney, NSW 2006, Australia.
  • Faculty of Health Sciences, The University of Sydney, Sydney, NSW 2050, Australia.
  • Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.

ORCID-Profile: Annukka Kallinen, Karine Mardon, Andrew P Montgomery, Muneer Ahamed, David Hibbs, Roger Fulton, Mark Connor, Michael Kassiou

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Kallinen, A., Mardon, K., Lane, S., Montgomery, A. P., Bhalla, R., Stimson, D. H. R., Ahamed, M., Cowin, G. J., Hibbs, D., Werry, E. L., Fulton, R., Connor, M., & Kassiou, M. (2023). Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00345

Vancouver

Kallinen A, Mardon K, Lane S, Montgomery AP, Bhalla R, Stimson DHR, et al. Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00345

BibTeX
@article{Kallinen2023,
  author = {Kallinen, Annukka and Mardon, Karine and Lane, Samuel and Montgomery, Andrew P and Bhalla, Rajiv and Stimson, Damion H R and Ahamed, Muneer and Cowin, Gary J and Hibbs, David and Werry, Eryn L and Fulton, Roger and Connor, Mark and Kassiou, Michael},
  title = {Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00345}
}
Kostenlos starten →